Novo Nordisk Long Term Debt 2010-2024 | NVO

Novo Nordisk long term debt for the quarter ending September 30, 2024 was $7.584B, a 160.72% increase year-over-year.

  • Novo Nordisk long term debt for 2023 was $2.981B, a 13.44% decline from 2022.
  • Novo Nordisk long term debt for 2022 was $3.443B, a 66.99% increase from 2021.
  • Novo Nordisk long term debt for 2021 was $2.062B, a 364.62% increase from 2020.

Novo Nordisk Long Term Debt 2010-2024 | NVO

  • Novo Nordisk long term debt for 2023 was $2.981B, a 13.44% decline from 2022.
  • Novo Nordisk long term debt for 2022 was $3.443B, a 66.99% increase from 2021.
  • Novo Nordisk long term debt for 2021 was $2.062B, a 364.62% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$354.3B
Merck (MRK)$255.9B
Novartis AG (NVS)$218.9B
AstraZeneca (AZN)$200.6B
Pfizer (PFE)$155.6B
Sanofi (SNY)$131.3B
Innoviva (INVA)$1.3B